Navigation of each product type

Our recommended contents

Our recommended contents

Here begins the text.

The 1st Subcommittee on Genome Editing

Thursday, November 8, 2018 13:00-15:00

Introduction of the Subcommittee Members
About the Science Board
Purpose of Establishment and Future Plan on Subcommittee
- Points to Consider for Risk Assessment of the Genome Editing Products (Dr. Teruhide Yamaguchi, Chairperson on Subcommittee)
Member's lecture
- Latest Summary of Genome Editing Technology (Dr. Tomoji Mashimo, a Member)
- Safety of Genome Editing Technology (Dr. Kohnosuke Mitani, a Member)
Others

Seating Chart
Classification of How to Handle the Handouts
1.	List of the Subcommittee Members
2.	About the Science Board
3.	Lecture Materials (Dr. Teruhide Yamaguchi, Chairperson on Subcommittee)
4.	Lecture Materials (Dr. Tomoji Mashimo, a Member)
5.	Lecture Materials (Dr. Kohnosuke Mitani, a Member)
Ref.1	Provision of the Establishment of PMDA Science Board
Ref.2	Provision of the PMDA Science Board Subcommittees
Ref.3	Rules of Commission of the Member of the Science Board and the Subcommittees (to Avoid Conflict of Interests)
Ref.4	Standards of Handling Meeting Minutes and Other Materials
Ref.5	Points to Be Checked to Invite External Experts
Ref.6	Points to Be Confirmed on Operation of the Working Group
Ref.7	Cases of Past Reports, English Translations and Publications

Pmda - Pharmaceuticals and Medical Devices Agency

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan